|
1 Year | 3 Years | 5 Years | 10 Years |
|---|---|---|---|---|
TOTAL FUND |
1.9 |
9.9 |
13.8 |
6.8 |
Hybrid Index |
2.3 |
9.9 |
14.2 |
6.4 |
|
||||
Domestic Equity (total) |
(7.0) |
5.6 |
11.8 |
4.6 |
Domestic Equity Benchmark |
(6.1) |
6.1 |
12.1 |
3.9 |
Alliance Capital |
0.5 |
7.0 |
8.5 |
3.7 |
AllianceBernstein |
(13.4) |
4.6 |
11.5 |
5.4 |
American Century |
(10.0) |
N/A |
N/A |
N/A |
Artisan Partners |
(11.6) |
2.3 |
N/A |
N/A |
EARNEST Partners |
(5.4) |
N/A |
N/A |
N/A |
GAMCO Investors |
(4.4) |
8.5 |
15.4 |
8.6 |
TCW Asset |
(10.6) |
3.8 |
14.3 |
N/A |
|
||||
International Equity (total) |
(3.3) |
12.9 |
19.8 |
6.7 |
International Equity Benchmark |
(2.3) |
13.8 |
21.9 |
6.6 |
AllianceBernstein |
(8.2) |
13.4 |
22.0 |
9.4 |
Capital Guardian |
0.2 |
14.0 |
20.2 |
8.3 |
JP Morgan |
(3.4) |
N/A |
N/A |
N/A |
|
||||
Emerging Markets Equity (total) |
17.1 |
27.9 |
33.8 |
12.5 |
Emerging Markets Benchmark |
21.1 |
30.7 |
37.4 |
14.0 |
Capital Guardian |
23.0 |
33.2 |
36.3 |
12.9 |
Templeton Investment |
10.1 |
22.1 |
30.9 |
11.9 |
|
||||
Alternatives: Absolute Return Funds (total) |
9.7 |
8.0* |
7.2* |
N/A |
Alternatives: Absolute Return Benchmark |
9.6 |
9.4 |
8.2 |
8.7 |
Bridgewater Associates |
22.5 |
N/A |
N/A |
N/A |
Ramius Capital |
0.1 |
6.8 |
6.5 |
N/A |
|
||||
Alternatives: Private Equity (total) |
N/A |
N/A |
N/A |
N/A |
Alternatives: Private Equity Benchmark |
N/A |
N/A |
N/A |
N/A |
Cerberus Series Four |
N/A |
N/A |
N/A |
N/A |
Crosslink Crossover V ** |
N/A |
N/A |
N/A |
N/A |
JF Lehman Equity II |
N/A |
N/A |
N/A |
N/A |
MidOcean Partners III-A |
N/A |
N/A |
N/A |
N/A |
Oakwood Medical Investors V ** |
N/A |
N/A |
N/A |
N/A |
Quadrangle Capital Partners II |
N/A |
N/A |
N/A |
N/A |
RiverVest Venture Fund II |
N/A |
N/A |
N/A |
N/A |
Thompson Street II |
N/A |
N/A |
N/A |
N/A |
Vectis Life Sciences Fund I |
N/A |
N/A |
N/A |
N/A |
Vestar Capital Partners V |
N/A |
N/A |
N/A |
N/A |
Warburg Pincus Private Equity X^ |
N/A |
N/A |
N/A |
N/A |
Welsh, Carson, Anderson & Stowe X |
N/A |
N/A |
N/A |
N/A |
|
||||
Real Estate (total) |
14.0 |
16.4^^ |
13.2^^ |
11.4^^ |
Real Estate Benchmark |
15.8 |
17.5 |
15.1 |
12.9 |
RREEF America II |
13.6 |
14.7 |
13.3 |
N/A |
TA Realty Associates Fund V |
15.9 |
23.9 |
19.0 |
N/A |
TA Realty Associates Fund VIII ** |
N/A |
N/A |
N/A |
N/A |
|
||||
Global Fixed Income (total) |
9.8 |
5.3 |
5.7 |
6.2 |
Global Fixed Income Benchmark |
11.2 |
6.0 |
5.9 |
6.2 |
Capital Guardian |
14.0 |
6.2 |
7.3 |
6.5 |
PIMCO |
5.6 |
4.3 |
4.1 |
5.8 |
|
||||
TIPS (Treasury Inflation-Protected) (total) |
N/A |
N/A |
N/A |
N/A |
TIPS Benchmark |
14.5 |
6.7 |
6.7 |
8.0 |
NISA ** |
N/A |
N/A |
N/A |
N/A |
PIMCO ** |
N/A |
N/A |
N/A |
N/A |
|
||||
Consumer Price Index |
4.0 |
3.4 |
3.0 |
2.8 |
* Includes returns of partial periods for DKR.
** Crosslink, Oakwood, TA Fund VIII, NISA, and PIMCO TIPS initial funding third quarter 2007.
^ Warburg initial funding fourth quarter 2007.
^^ Includes returns of partial periods for TA Funds III and/or IV.